SOFT TISSUE SARCOMA ADULT
Clinical trials for SOFT TISSUE SARCOMA ADULT explained in plain language.
Never miss a new study
Get alerted when new SOFT TISSUE SARCOMA ADULT trials appear
Sign up with your email to follow new studies for SOFT TISSUE SARCOMA ADULT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental cancer drug enters first human trials
Disease control OngoingThis is the first human study of an experimental drug called SON-1010 for adults with advanced solid tumors that have stopped responding to standard treatments. Researchers will test increasing doses in 42 patients to find the safest amount and understand how the drug works in th…
Matched conditions: SOFT TISSUE SARCOMA ADULT
Phase: PHASE1 • Sponsor: Sonnet BioTherapeutics • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
Double-Duty immune attack tested against tough sarcoma
Disease control OngoingThis study is testing whether adding a second immunotherapy drug (relatlimab) to a standard one (nivolumab) works better for controlling advanced soft tissue sarcoma. It enrolled 67 adults whose cancer has spread and is no longer responding to other treatments. Patients were rand…
Matched conditions: SOFT TISSUE SARCOMA ADULT
Phase: PHASE2 • Sponsor: Institut Bergonié • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
Researchers track how cancer surgery impacts Seniors' daily lives
Knowledge-focused OngoingThis study aims to understand how surgery for soft tissue sarcoma in the leg affects physical function and quality of life in patients aged 70 and older. Researchers will follow 100 patients for three years after their surgery, collecting information about their mobility, daily a…
Matched conditions: SOFT TISSUE SARCOMA ADULT
Phase: NA • Sponsor: Institut Bergonié • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC